DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,318,000 | +1.6% | 23,675 | -3.7% | 1.81% | +4.7% |
Q4 2017 | $2,281,000 | +1.2% | 24,575 | -6.5% | 1.73% | +2.2% |
Q3 2017 | $2,254,000 | +0.6% | 26,277 | -1.0% | 1.69% | -2.9% |
Q2 2017 | $2,240,000 | -2.1% | 26,544 | -0.8% | 1.74% | -2.6% |
Q1 2017 | $2,288,000 | +4.7% | 26,749 | -4.7% | 1.79% | +6.8% |
Q4 2016 | $2,185,000 | -2.9% | 28,074 | -2.2% | 1.68% | -1.5% |
Q3 2016 | $2,251,000 | -22.1% | 28,719 | +0.4% | 1.70% | -25.4% |
Q2 2016 | $2,889,000 | +9.6% | 28,604 | +2.9% | 2.28% | +2.6% |
Q1 2016 | $2,637,000 | +1.1% | 27,804 | -1.0% | 2.22% | -10.7% |
Q4 2015 | $2,609,000 | +5.8% | 28,089 | -2.9% | 2.49% | -3.5% |
Q3 2015 | $2,465,000 | -4.7% | 28,934 | -4.3% | 2.58% | +17.7% |
Q2 2015 | $2,586,000 | -3.7% | 30,219 | -4.4% | 2.19% | +0.6% |
Q1 2015 | $2,684,000 | +3.9% | 31,614 | +4.9% | 2.18% | +2.5% |
Q4 2014 | $2,584,000 | +6.5% | 30,149 | -5.6% | 2.12% | +7.5% |
Q3 2014 | $2,427,000 | -5.0% | 31,939 | -1.5% | 1.97% | +0.1% |
Q2 2014 | $2,554,000 | +4.6% | 32,434 | -0.4% | 1.97% | -0.8% |
Q1 2014 | $2,442,000 | -4.4% | 32,559 | -1.6% | 1.99% | -6.0% |
Q4 2013 | $2,554,000 | – | 33,084 | – | 2.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |